EP3419623
METHODS FOR USING FXR AGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.2.2017EP published:
29.9.2021EP application number:
17707959.7
EPO information:
European Patent Register
Max expiry date:
16.2.2037
Title:
METHODS FOR USING FXR AGONISTS
Timeline
Today
17.2.2017EP application
29.9.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
LAFFITTE, BryanAddress:
San Diego, California 92121, US
Name:
BADMAN, MichaelAddress:
Cambridge, Massachusetts 02139, US
Name:
CHEN, JinAddress:
East Hanover, New Jersey 07936, US
Name:
LINDGREN, SamAddress:
4002 Basel, CH
Priority
Number:
201662298117 PDate:
22.2.2016Country:
US
Number:
201662420702 PDate:
11.11.2016Country:
US
Classification
Categories:
A61K 31/46, A61P 1/00, A61P 1/16, A61K 31/4748, A61K 31/497, A61K 31/506